AA
ALK-Abelló A/S Stock: price and insider trades · Denmark
ALK-Abelló A/S: what insiders have been doing
We have very little insider data for ALK-Abelló A/S so far. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finanstilsynet DK and describes the past, not future prices; it is not investment advice.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,617 of 26,897 companies
62.4
score / 100
Value39
Quality86
FCF yld2.9%
Earn yld2.4%
EV/EBITDA25.1x
ROE21%
Gross mgn67%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
DKK 224.00
Analyst consensus
4 analysts1.40/5
DKK 290.00Target DKK 298.75(+33%)DKK 305.00
Income statement
RevenueDKK 6.3B
Gross profitDKK 4.2B67% margin
EBITDADKK 2B32% margin
Net incomeDKK 1.2B19.5% margin
Valuation
PER (trailing)38.6x
PER (forward)29.9x
P/Book7.6x
Beta0.71
Balance sheet & cash
Market capDKK 49.6B
Total debtDKK 418M
Free Cash FlowDKK 1.5B
Debt / Equity6%
Profitability & ownership
ROE20.9%
ROA12.6%
% institutions64.5%
Declarations0 total
No declarations found
0 of 0 declarations
About ALK-Abelló A/S
ALK-Abelló A/S is a Danish company focused on developing treatments for allergies. It specializes in allergen immunotherapy and offers solutions for patients suffering from respiratory and food allergies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
